High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Innovative, Generic), By Dosage Form (Injectable, Creams), By Application, By Synthesis, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product Type
                        1.1.2. Application
                        1.1.3. Synthesis
                        1.1.4. Dosage Form
                        1.1.5. Regional scope
                        1.1.6. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                        1.6.2. Volume price analysis (Model 2)
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                        1.9.1. Objective 1
                        1.9.2. Objective 2
                        1.9.3. Objective 3
                        1.9.4. Objective 4
Chapter 2. Executive Summary
                    2.1. Market Outlook
Chapter 3. High Potency API (HPAPI) Contract Manufacturing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                            3.3.1.1 Increasing pipeline of pharmaceutical drugs
                            3.3.1.2 Growing expansion of HPAPI production facilities
                            3.3.1.3 Increasing trend of outsourcing
                            3.3.1.4 Increasing application of HPAPIs
                        3.3.2. Market restraint analysis
                            3.3.2.1 Significant investments and complicated safety and handling specifications associated with the production of HPAPIs
                    3.3. Penetration & Growth Prospect Mapping
                    3.4. Covid-19 Impact & Recovery Analysis
                    3.5. Major Deals and Strategic Alliances Analysis
                    3.6. Industry Analysis - Porter’s
                    3.7. PESTLE Analysis
Chapter 4. High Potency API (HPAPI) Contract Manufacturing Market: Product Type Segment Analysis
                    4.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
                    4.2. High Potency API (HPAPI) Contract Manufacturing Market: Product Type Market Share Analysis, 2021 & 2030
                        4.2.1. Innovative
                            4.2.1.1. Innovative Market, 2018 - 2030 (USD Million)
                        4.2.2. Generic
                            4.2.2.1. Generic Market, 2018 - 2030 (USD Million)
Chapter 5. High Potency API (HPAPI) Contract Manufacturing Market: Application Segment Analysis
                    5.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
                    5.2. High Potency API (HPAPI) Contract Manufacturing Market: Application Market Share Analysis, 2021 & 2030
                        5.2.1. Oncology
                            5.2.1.1. Oncology Market, 2018 - 2030 (USD Million)
                        5.2.2. Hormonal Disorders
                            5.2.2.1. Hormonal disorders Market, 2018 - 2030 (USD Million)
                        5.2.3. Glaucoma
                            5.2.3.1. Glaucoma Market, 2018 - 2030 (USD Million)
                        5.2.4. Others
                            5.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. High Potency API (HPAPI) Contract Manufacturing Market: Synthesis Segment Analysis
                    6.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
                    6.2. High Potency API (HPAPI) Contract Manufacturing Market: Synthesis Market Share Analysis, 2021 & 2030
                        6.2.1. Synthetic
                            6.2.1.1. Synthetic Market, 2018 - 2030 (USD Million)
                        6.2.2. Biotech
                            6.2.2.1. Biotech Market, 2018 - 2030 (USD Million)
Chapter 7. High Potency API (HPAPI) Contract Manufacturing Market: Dosage Form Segment Analysis
                    7.1. High Potency API (HPAPI) Contract Manufacturing Market: Definition & Scope
                    7.2. High Potency API (HPAPI) Contract Manufacturing Market: Dosage form Market Share Analysis, 2021 & 2030
                        7.2.1. Injectable
                            7.2.1.1. Injectable Market, 2018 - 2030 (USD Million)
                        7.2.2. Oral Solids
                            7.2.2.1. Oral solids Market, 2018 - 2030 (USD Million)
                        7.2.3. Creams
                            7.2.3.1. Creams Market, 2018 - 2030 (USD Million)
                        7.2.4. Others
                            7.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. High Potency API (HPAPI) Contract Manufacturing Market: Regional Analysis
                    8.1. Healthcare Finance Solutions: Regional market share analysis, 2021 & 2030
                    8.2. North America
                        8.2.1. North America High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.2.2. U.S.
                            8.2.2.1. U.S. High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.2.3. Canada
                            8.2.3.1. Canada High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                    8.3. Europe
                        8.3.1. Europe High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.3.2. U.K.
                            8.3.2.1. U.K. High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.3.3. Germany
                            8.3.3.1. Germany High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.3.4. Italy
                            8.3.4.1. Italy High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.3.5. Spain
                            8.3.5.1. Spain High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                        8.3.6. France
                            8.3.6.1. France High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                    8.4. Asia Pacific
                        8.4.1. Asia Pacific High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                        8.4.2. China
                            8.4.2.1. China High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.4.3. India
                            8.4.3.1. India High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                        8.4.4. Japan
                            8.4.4.1. Japan High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                        8.4.5. Australia
                            8.4.5.1. Australia High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                    8.5. Latin America
                        8.5.1. Latin America High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030(USD Million)
                        8.5.2. Brazil
                            8.5.2.1. Brazil High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.5.3. Mexico
                            8.5.3.1. Mexico High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.5.4. Argentina
                            8.5.4.1. Argentina High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                    8.6. MEA
                        8.6.1. MEA High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.6.2. South Africa
                            8.6.2.1. South Africa High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.6.3. South Arabia
                            8.6.3.1. South Africa High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
                        8.6.4. UAE
                            8.6.4.1. UAE High Potency API (HPAPI) Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company Profiles
                        9.1.1. Piramal Pharma Solutions
                            9.1.1.1. Company overview
                            9.1.1.2. Financial performance
                            9.1.1.3. Service benchmarking
                            9.1.1.4. Strategic initiatives
                        9.1.2. Lonza
                            9.1.2.1. Company overview
                            9.1.2.2. Financial performance
                            9.1.2.3. Service benchmarking
                            9.1.2.4. Strategic initiatives
                        9.1.3. Catalent Inc
                            9.1.3.1. Company overview
                            9.1.3.2. Financial performance
                            9.1.3.3. Service benchmarking
                            9.1.3.4. Strategic initiatives
                        9.1.4. VxP Pharma, Inc.
                            9.1.4.1. Company overview
                            9.1.4.2. Financial performance
                            9.1.4.3. Service benchmarking
                            9.1.4.4. Strategic initiatives
                        9.1.5. Pfizer CentreOne
                            9.1.5.1. Company overview
                            9.1.5.2. Financial performance
                            9.1.5.3. Service benchmarking
                            9.1.5.4. Strategic initiatives
                        9.1.6. Gentec Pharmaceutical Group
                            9.1.6.1. Company overview
                            9.1.6.2. Financial performance
                            9.1.6.3. Service benchmarking
                            9.1.6.4. Strategic initiatives
                        9.1.7. AbbVie
                            9.1.7.1. Company overview
                            9.1.7.2. Financial performance
                            9.1.7.3. Service benchmarking
                            9.1.7.4. Strategic initiatives
                        9.1.8. Aurigene Pharmaceutical Services Ltd.
                            9.1.8.1. Company overview
                            9.1.8.2. Financial performance
                            9.1.8.3. Service benchmarking
                            9.1.8.4. Strategic initiatives
                        9.1.9. CordenPharma International
                            9.1.9.1. Company overview
                            9.1.9.2. Financial performance
                            9.1.9.3. Service benchmarking
                            9.1.9.4. Strategic initiatives
                        9.1.10. Curia Global, Inc.
                            9.1.10.1. Company overview
                            9.1.10.2. Financial performance
                            9.1.10.3. Service benchmarking
                            9.1.10.4. Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Abbreviation

List of Figures

FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 QFD modeling for market share assessment
FIG. 6 Market formulation & validation
FIG. 7 High Potency API (HPAPI) Contract Manufacturing Market: Market snapshot
FIG. 8 High Potency API (HPAPI) Contract Manufacturing Market: Market segmentation
FIG. 9 High Potency API (HPAPI) Contract Manufacturing Market Strategy framework
FIG. 10 Parent market outlook
FIG. 11 Related/ancillary market outlook
FIG. 12 High Potency API (HPAPI) Contract Manufacturing Market driver impact
FIG. 13 High Potency API (HPAPI) Contract Manufacturing Market restraint impact
FIG. 14 High Potency API (HPAPI) Contract Manufacturing Market porter’s five forces analysis
FIG. 15 High Potency API (HPAPI) Contract Manufacturing Market PESTEL analysis
FIG. 16 High Potency API (HPAPI) Contract Manufacturing Market segment dashboard
FIG. 17 High Potency API (HPAPI) Contract Manufacturing Market: Product type movement Analysis
FIG. 18 Innovative estimates and forecast, 2018 - 2030 (USD Million)
FIG. 19 Generic estimates and forecast, 2018 - 2030 (USD Million)
FIG. 20 High Potency API (HPAPI) Contract Manufacturing Market segment dashboard
FIG. 21 High Potency API (HPAPI) Contract Manufacturing Market: Application movement Analysis
FIG. 22 Oncology estimates and forecast, 2018 - 2030 (USD Million)
FIG. 23 Hormonal disorders estimates and forecast, 2018 - 2030 (USD Million)
FIG. 24 Glaucoma estimates and forecast, 2018 - 2030 (USD Million)
FIG. 25 Others estimates and forecast, 2018 - 2030 (USD Million)
FIG. 26 High Potency API (HPAPI) Contract Manufacturing Market: Synthesis movement Analysis
FIG. 27 Synthetic estimates and forecast, 2018 - 2030 (USD Million)
FIG. 28 Biotech estimates and forecast, 2018 - 2030 (USD Million)
FIG. 29 High Potency API (HPAPI) Contract Manufacturing Market: Dosage forms movement Analysis
FIG. 30 Injectable estimates and forecast, 2018 - 2030 (USD Million)
FIG. 31 Oral solids estimates and forecast, 2018 - 2030 (USD Million)
FIG. 32 Creams estimates and forecast, 2018 - 2030 (USD Million)
FIG. 33 Others estimates and forecast, 2018 - 2030 (USD Million)
FIG. 34 Global High Potency API (HPAPI) Contract Manufacturing Market: Regional movement analysis
FIG. 35 Global High Potency API (HPAPI) Contract Manufacturing Market: Regional outlook and key takeaways
FIG. 36 North America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 37 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 38 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 39 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 40 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 41 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 43 Italy market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Spain market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 China market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 47 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 55 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)